FDA inspection
Cadila Pharmaceuticals Limited: FDA inspection ending May 3, 2018
FDA inspection 1052117 · Voluntary Action Indicated (VAI) · Ahmedabad
Key facts
| Inspection ID | 1052117 |
|---|---|
| Firm | Cadila Pharmaceuticals Limited |
| FEI number | 3007684569 |
| Address | 1389 Trasad Road, Dholka |
| City | Ahmedabad |
| Country | India |
| Fiscal year | 2018 |
| Inspection end date | May 3, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data